TipRanks
Advertisement
Advertisement
BENEFIT-HF Trial Design Publication Highlights CVRx Heart Failure Strategy
PremiumPrivate CompaniesBENEFIT-HF Trial Design Publication Highlights CVRx Heart Failure Strategy
4M ago
CVRx Highlights ASCEND Fellows Graduation and Heart Failure Education Initiative
Premium
Private Companies
CVRx Highlights ASCEND Fellows Graduation and Heart Failure Education Initiative
4M ago
Educational Initiative Underscores CVRx Focus on Heart Failure Leadership Development
Premium
Private Companies
Educational Initiative Underscores CVRx Focus on Heart Failure Leadership Development
4M ago
CVRx Reports Double-Digit Revenue Growth and Expands Barostim U.S. Footprint
PremiumPrivate CompaniesCVRx Reports Double-Digit Revenue Growth and Expands Barostim U.S. Footprint
5M ago
CVRx Marks First Enrollment in Large-Scale BENEFIT-HF Heart Failure Trial
Premium
Private Companies
CVRx Marks First Enrollment in Large-Scale BENEFIT-HF Heart Failure Trial
5M ago
Large BENEFIT-HF Trial Enrollment Highlights CVRx Barostim Growth Ambitions
Premium
Private Companies
Large BENEFIT-HF Trial Enrollment Highlights CVRx Barostim Growth Ambitions
5M ago
CVRx Nominates Medical Device Executive Michael Dale to Board of Directors
PremiumPrivate CompaniesCVRx Nominates Medical Device Executive Michael Dale to Board of Directors
5M ago
CVRx Board Nomination Signals Focus on Commercial Scaling of Barostim
Premium
Private Companies
CVRx Board Nomination Signals Focus on Commercial Scaling of Barostim
5M ago
CVRx Highlights Barostim Heart Failure Session and BENEFIT-HF Trial Focus at ISHLT 2026
Premium
Private Companies
CVRx Highlights Barostim Heart Failure Session and BENEFIT-HF Trial Focus at ISHLT 2026
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―